Skip to content

Minimally invasive treatment of intercondylar eminence fracture of tibial plateau using bidirectional rapid reductor: a randomized controlled trial

Minimally invasive treatment of intercondylar eminence fracture of tibial plateau using bidirectional rapid reductor: a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021306
Enrollment
Unknown
Registered
2019-02-12
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intercondylar eminence fracture of tibial plateau

Interventions

Homeopathic treatment group:Bidirectional traction and retrograde screw fixation
Open reduction group:Open reduction and internal fixation
Arthroscopic group:Arthroscopically-assited reduction and internal fixation

Sponsors

The Third Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients admitted to the third hospital of Hebei Medical University from February 2019 to February 2020 and confirmed with the intercondylar eminence fracture of tibial plateau (patients with simple intercondylar eminence fracture or tibial plateau fracture combined with intercondylar eminence fracture); 2. Aged 18 to 80 years, with normal movement of both lower limbs before injury; 3. Patients with closed fracture and the time from injury to operation is less than 3 weeks; 4. Patients without other peripheral knee fractures, such as patella fracture, femoral intercondylar fracture, etc.; 5. Agree to accept the minimally invasive surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with pathological fracture or severe knee degeneration; 2. Patients with old fractures (more than 3 weeks); 3. Have serious systemic diseases, such as renal failure, heart failure, etc.; 4. A history of mental disorders or nerves.

Design outcomes

Primary

MeasureTime frame
Blood loss;Operation time;Healing time;Full load time;2-month IKDC scores;3-month IKDC scores;6-month IKDC scores;1-year IKDC scores;

Countries

China

Contacts

Public ContactZhang Yingze
dryzzhang@126.com+86 0311 88603610

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026